Urs B. Schaad

5.0k total citations
94 papers, 3.5k citations indexed

About

Urs B. Schaad is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Urs B. Schaad has authored 94 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Epidemiology, 27 papers in Pulmonary and Respiratory Medicine and 21 papers in Pharmacology. Recurrent topics in Urs B. Schaad's work include Pneumonia and Respiratory Infections (26 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers) and Bacterial Infections and Vaccines (14 papers). Urs B. Schaad is often cited by papers focused on Pneumonia and Respiratory Infections (26 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers) and Bacterial Infections and Vaccines (14 papers). Urs B. Schaad collaborates with scholars based in Switzerland, United States and Italy. Urs B. Schaad's co-authors include George H. McCracken, Ulrich Heininger, John D. Nelson, Jan Bonhoeffer, Gurli Baer, Paul S. Lietman, John E. Burkhardt, Juan N. Walterspiel, J Wedgwood and Susanne Suter and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and PEDIATRICS.

In The Last Decade

Urs B. Schaad

93 papers receiving 3.3k citations

Peers

Countries citing papers authored by Urs B. Schaad

Since Specialization

Citations

This map shows the geographic impact of Urs B. Schaad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urs B. Schaad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urs B. Schaad more than expected).

Fields of papers citing papers by Urs B. Schaad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Urs B. Schaad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urs B. Schaad. The network helps show where Urs B. Schaad may publish in the future.

Co-authorship network of co-authors of Urs B. Schaad

This figure shows the co-authorship network connecting the top 25 collaborators of Urs B. Schaad. A scholar is included among the top collaborators of Urs B. Schaad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Urs B. Schaad. Urs B. Schaad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Actinomyces neuiiIsolated From a 20-Month-Old Girl With Cervical Lymphadenitis 2014 ·Journal of the Pediatric Infectious Diseases Society ·(unknown), Elisabeth Bruder, Daniel Goldenberger, Johannes Mayr, Urs B. Schaad, Nicole Ritz	8
2	Procalcitonin Guidance to Reduce Antibiotic Treatment of Lower Respiratory Tract Infection in Children and Adolescents (ProPAED): A Randomized Controlled Trial 2013 ·PLoS ONE ·Gurli Baer, Philipp Baumann, Michael Buettcher, Ulrich Heininger, (unknown), Juliane Schäfer, Heiner C. Bucher, Daniel Trachsel, Jacques Schneider, (unknown), (unknown), (unknown), (unknown), (unknown), Philipp Schüetz, Beat Müeller, Gabor Szinnai, Urs B. Schaad, Jan Bonhoeffer	73
3	Do We Know When, What and For How Long to Treat? 2012 ·The Pediatric Infectious Disease Journal ·Susanna Esposito, Robert Cohen, Javier Díez‐Domingo, (unknown), David Greenberg, Ulrich Heininger, Markus Knuf, Irja Lutsar, Nicola Principi, Fernanda Rodrigues, Mike Sharland, Vana Spoulou, George A. Syrogiannopoulos, Vytautas Usonis, Anne Vergison, Urs B. Schaad	87
4	OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review 2010 ·World Journal of Pediatrics ·Urs B. Schaad	88
5	Pediatric Infectious Diseases 2008 ·46th Annual Meeting ·Urs B. Schaad	4
6	Potential Role of Fluoroquinolone Therapy in Childhood Otitis Media 2004 ·The Pediatric Infectious Disease Journal ·Ron Dagan, Adriano Arguedas, Urs B. Schaad	16
7	Cost-effectiveness of a pneumococcal conjugate immunisation program for infants in Switzerland 2003 ·Vaccine ·S.M. Ess, Urs B. Schaad, Alain Gervaix, (unknown), Thomas D. Szucs	45
8	Immunostimulation with OM-85 in Children with Recurrent Infections of the Upper Respiratory Tract 2002 ·CHEST Journal ·Urs B. Schaad, (unknown), (unknown)	87
9	The Battle against Emerging Antibiotic Resistance: Should Fluoroquinolones Be Used to Treat Children? 2002 ·Clinical Infectious Diseases ·Lionel A. Mandell, Lance R. Peterson, Richard Wise, David C. Hooper, Donald E. Low, Urs B. Schaad, Keith P. Klugman, Patrice Courvalin	58
10	Acute Community-Acquired Diarrhea Requiring Hospital Admission in Swiss Children 2000 ·Clinical Infectious Diseases ·(unknown), André P. Burnens, (unknown), (unknown), Rodo O. von Vigier, Urs B. Schaad, Christoph Aebi, Mario G. Bianchetti	65
11	Cefepime vs. ceftazidime treatment of pyelonephritis: a European, randomized, controlled study of 300 pediatric cases 1998 ·The Pediatric Infectious Disease Journal ·Urs B. Schaad, Juhani Eskola, (unknown), (unknown), Shai Ashkenazi, Vassiliki Syriopoulou, (unknown), Veerle de Pril, (unknown), C. Rollin	26
12	Acute encephalitis in Swiss children: Aetiology and outcome 1998 ·European Journal of Paediatric Neurology ·(unknown), Filippo Donati, F Vassella, Urs B. Schaad, Mario G. Bianchetti	10
13	Toward an integrated program for patient care in pediatric infections 1997 ·The Pediatric Infectious Disease Journal ·Urs B. Schaad	3
14	Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis 1995 ·The Journal of Pediatrics ·Aloïs B. Lang, Urs B. Schaad, A Rüdeberg, J Wedgwood, John U. Que, E Fürer, Stanley J. Cryz	41
15	Morphologic studies for skeletal toxicity after prolonged ciprofloxacin therapy in two juvenile cystic fibrosis patients 1992 ·The Pediatric Infectious Disease Journal ·Urs B. Schaad, (unknown), J Wedgwood, (unknown)	45
16	Serotype-Specific Serum IgG Antibodies to Lipopolysaccharides of Pseudomonas aeruginosa in Cystic Fibrosis: Correlation to Disease, Subclass Distribution, and Experimental Protective Capacity 1990 ·Pediatric Research ·Urs B. Schaad, Aloïs B. Lang, J Wedgwood, (unknown), (unknown)	21
17	Effects of Antimicrobial Agents Used for Therapy of CNS Infections on Dissociated Brain Cell Cultures 1988 ·Pediatric Research ·Urs B. Schaad, (unknown), (unknown), (unknown)	7
18	Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis 1987 ·The Journal of Pediatrics ·Urs B. Schaad, (unknown), Susanne Suter, Richard Kraemer	86
19	Melioidosis 1982 ·The Journal of Pediatrics ·Pisespong Patamasucon, Urs B. Schaad, John D. Nelson	14
20	Management of atypical mycobacterial lymphadenitis in childhood: A review based on 380 cases 1979 ·The Journal of Pediatrics ·Urs B. Schaad, Theodore P. Votteler, George H. McCracken, John D. Nelson	143

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact